World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: REBEC
Last refreshed on: 29 May 2023
Main ID:  RBR-88b5jr
Date of registration: 11/09/2014
Prospective Registration: No
Primary sponsor: Conselho Nacional de Desenvolvimento Científico e Tecnológico (
Public title: Diagnostic study of Dengue in Emergency Care
Scientific title: Pragmatic Diagnostic Trial of Cinical-Laboratory Algorithm for Dengue in Emergency Care Units in Rio de Janeiro
Date of first enrolment: 05/04/2013
Target sample size:
Recruitment status: Recruiting
URL:  http://ensaiosclinicos.gov.br/rg/RBR-88b5jr
Study type:  Intervention
Study design:  Two arms, double-blind, paralle, randomized, diagnostic clinical trial  
Phase:  N/A
Countries of recruitment
Brazil
Contacts
Name: Sibelle Nogueira   Buonora
Address:  Rua Bruno Lobo 50 Ilha do Fundão 21000-000 Rio de Janeiro Brazil
Telephone: +55(21)998727696
Email: sibellebuonora@gmail.com
Affiliation:  Universidade Federal do Rio de Janeiro
Name: Sonia Regina Lambert   Passos
Address:  Av Brasil 4036 sala 201 A Manguinhos 21040-361 Manguinhos Brazil
Telephone: +55(21)38829208
Email: sonia.lambert@ipec.fiocruz.br
Affiliation:  Instituto de Pesquisa Clínica Evandro Chagas
Key inclusion & exclusion criteria
Inclusion criteria: Patients of both genders over 18 years assisted in Emergency Care Units in Rio de Janeiro, with fever for up to 3 days without other infectious etiology.
Exclusion criteria: pediatric patients and those with other infectious etiology.

Age minimum: 18Y
Age maximum: 100Y
Gender: -
Health Condition(s) or Problem(s) studied
C02.081.270
Dengue
Intervention(s)
Procedure/surgery
Different algorithms clinical diagnosis of dengue will be compared in a outpatient unit. Control Group ( clinical algorithm proposed by WHO 2009): 150 subjects will undergo the standard protocol for the diagnosis of dengue consisting of at least two of seven signs and symptoms (fever, myalgia, asthenia, headache, retrorbitrária pain, arthralgia, rash) and Intervention Group: 150 individuals will be subjected to the experimental protocol for the diagnosis of dengue, which consists of (lymphadenopathy, leukocyte count below 6000/mm3, rash, thrombocytopenia, ocular congestion. Both groups will be subjected to rapid immunochromatographic dengue dengue NS1 (Bio-Easy)
E01.370
Primary Outcome(s)
Accurate, more sensitive and specific case definition to guide the rapid test request and appropriate referral of the case. To compare Likelihood Ratios and Diagnostic Odds Ratios of each model.
Reliability of each clinical prediction rule measured by kappa values ??interpreted according to Landis and Koch, 1977.
Secondary Outcome(s)
Need to review clinical case defined as at least a return to emergency unit
Secondary ID(s)
Source(s) of Monetary Support
Fundação Oswaldo Cruz
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Secondary Sponsor(s)
Fundação Oswaldo Cruz
Instituto de Pesquisa Clínica Evandro Chagas
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history